/2759MO DAREON®-8: A phase I trial of first-line obrixtamig plus chemotherapy and atezolizumab in extensive-stage small cell lung carcinoma (ES-SCLC)

Reviews

Join the dialogue

Submit a peer review to improve the scientific record